Beilmann-Lehtonen I - Search Results

1

High tissue expression of TLRs combined with high density of tumor infiltrating lymphocytes predicts a better prognosis in colorectal cancer patients.

Beilmann-Lehtonen I, Kasurinen J, Hagström J, Kaprio T, Böckelman C, Haglund C. Beilmann-Lehtonen I, et al. PLoS One. 2023 Jan 17;18(1):e0280085. doi: 10.1371/journal.pone.0280085. eCollection 2023. PLoS One. 2023. PMID: 36649244 Free PMC article.

2

Serum MMP-8 and TIMP-1 predict prognosis in colorectal cancer.

Böckelman C, Beilmann-Lehtonen I, Kaprio T, Koskensalo S, Tervahartiala T, Mustonen H, Stenman UH, Sorsa T, Haglund C. Böckelman C, et al. BMC Cancer. 2018 Jun 22;18(1):679. doi: 10.1186/s12885-018-4589-x. BMC Cancer. 2018. PMID: 29929486 Free PMC article.

3

The prognostic role of tissue TLR2 and TLR4 in colorectal cancer.

Beilmann-Lehtonen I, Böckelman C, Mustonen H, Koskensalo S, Hagström J, Haglund C. Beilmann-Lehtonen I, et al. Virchows Arch. 2020 Nov;477(5):705-715. doi: 10.1007/s00428-020-02833-5. Epub 2020 May 19. Virchows Arch. 2020. PMID: 32424768 Free PMC article.

4

High Tissue TLR5 Expression Predicts Better Outcomes in Colorectal Cancer Patients.

Beilmann-Lehtonen I, Hagström J, Mustonen H, Koskensalo S, Haglund C, Böckelman C. Beilmann-Lehtonen I, et al. Oncology. 2021;99(9):589-600. doi: 10.1159/000516543. Epub 2021 Jun 17. Oncology. 2021. PMID: 34139707

5

Colon cancer patients with mismatch repair deficiency are more likely to present as acute surgical cases.

Gkekas I, Novotny J, Kaprio T, Beilmann-Lehtonen I, Fabian P, Edin S, Strigård K, Svoboda T, Hagström J, Barsova L, Jirasek T, Haglund C, Palmqvist R, Gunnarsson U. Gkekas I, et al. Eur J Cancer. 2021 Nov;157:1-9. doi: 10.1016/j.ejca.2021.07.027. Epub 2021 Aug 27. Eur J Cancer. 2021. PMID: 34461577

6

Elevated tumor expression of Astroprincin (FAM171A1) is an independent marker of poor prognosis in colon cancer.

Kaprio T, Lindström AM, Rasila T, Saavalainen O, Beilmann-Lehtonen I, Mustonen H, Haglund C, Andersson LC. Kaprio T, et al. BMC Gastroenterol. 2021 Sep 4;21(1):341. doi: 10.1186/s12876-021-01918-y. BMC Gastroenterol. 2021. PMID: 34481452 Free PMC article.

7

The Relationship between the Tissue Expression of TLR2, TLR4, TLR5, and TLR7 and Systemic Inflammatory Responses in Colorectal Cancer Patients.

Beilmann-Lehtonen I, Hagström J, Kaprio T, Stenman UH, Strigård K, Palmqvist R, Gunnarsson U, Böckelman C, Haglund C. Beilmann-Lehtonen I, et al. Oncology. 2021;99(12):790-801. doi: 10.1159/000518397. Epub 2021 Sep 8. Oncology. 2021. PMID: 34515203

8

TATI, TAT-2, and CRP as Prognostic Factors in Colorectal Cancer.

Björkman K, Kaprio T, Beilmann-Lehtonen I, Stenman UH, Böckelman C, Haglund C. Björkman K, et al. Among authors: beilmann lehtonen i. Oncology. 2022;100(1):22-30. doi: 10.1159/000518956. Epub 2021 Nov 18. Oncology. 2022. PMID: 34794144

9

Tumor-associated CD3- and CD8-positive immune cells in colorectal cancer: The additional prognostic value of CD8+-to-CD3+ ratio remains debatable.

Kasurinen J, Hagström J, Kaprio T, Beilmann-Lehtonen I, Haglund C, Böckelman C. Kasurinen J, et al. Among authors: beilmann lehtonen i. Tumour Biol. 2022;44(1):37-52. doi: 10.3233/TUB-211571. Tumour Biol. 2022. PMID: 35404299 Free article.

10

Phenotypic subtypes predict outcomes in colorectal cancer.

Kasurinen J, Beilmann-Lehtonen I, Kaprio T, Hagström J, Haglund C, Böckelman C. Kasurinen J, et al. Among authors: beilmann lehtonen i. Acta Oncol. 2023 Mar;62(3):245-252. doi: 10.1080/0284186X.2023.2183779. Epub 2023 Mar 3. Acta Oncol. 2023. PMID: 36867078

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16 results

Search Page